1. Home
  2. BZH vs CDNA Comparison

BZH vs CDNA Comparison

Compare BZH & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BZH
  • CDNA
  • Stock Information
  • Founded
  • BZH 1985
  • CDNA 1998
  • Country
  • BZH United States
  • CDNA United States
  • Employees
  • BZH N/A
  • CDNA N/A
  • Industry
  • BZH Homebuilding
  • CDNA Medical Specialities
  • Sector
  • BZH Consumer Discretionary
  • CDNA Health Care
  • Exchange
  • BZH Nasdaq
  • CDNA Nasdaq
  • Market Cap
  • BZH 989.6M
  • CDNA 944.1M
  • IPO Year
  • BZH 1994
  • CDNA 2014
  • Fundamental
  • Price
  • BZH $31.28
  • CDNA $23.00
  • Analyst Decision
  • BZH Strong Buy
  • CDNA Buy
  • Analyst Count
  • BZH 3
  • CDNA 8
  • Target Price
  • BZH $39.67
  • CDNA $28.00
  • AVG Volume (30 Days)
  • BZH 234.2K
  • CDNA 932.2K
  • Earning Date
  • BZH 11-13-2024
  • CDNA 11-04-2024
  • Dividend Yield
  • BZH N/A
  • CDNA N/A
  • EPS Growth
  • BZH N/A
  • CDNA N/A
  • EPS
  • BZH 4.63
  • CDNA N/A
  • Revenue
  • BZH $2,169,445,000.00
  • CDNA $297,084,000.00
  • Revenue This Year
  • BZH $5.22
  • CDNA $18.61
  • Revenue Next Year
  • BZH $18.48
  • CDNA $8.54
  • P/E Ratio
  • BZH $6.64
  • CDNA N/A
  • Revenue Growth
  • BZH N/A
  • CDNA N/A
  • 52 Week Low
  • BZH $25.48
  • CDNA $6.07
  • 52 Week High
  • BZH $35.20
  • CDNA $34.84
  • Technical
  • Relative Strength Index (RSI)
  • BZH 45.85
  • CDNA 34.82
  • Support Level
  • BZH $30.65
  • CDNA $22.01
  • Resistance Level
  • BZH $31.75
  • CDNA $23.30
  • Average True Range (ATR)
  • BZH 0.96
  • CDNA 1.16
  • MACD
  • BZH -0.13
  • CDNA -0.17
  • Stochastic Oscillator
  • BZH 38.94
  • CDNA 17.61

About BZH Beazer Homes USA Inc.

Beazer Homes USA Inc is an construction company that focuses on residential construction. The company specializes in single-family housing and multi-unit building construction in over 13 states and over 22 metro markets. Beazer Homes builds homes and communities that target first-time, move-up, and luxury homebuyers with an average selling price of roughly $300,000. From a geographic perspective, home sales in the western and eastern United States have been the leading sources of revenue for the company. Key metro areas include Atlanta, Las Vegas, Los Angeles, Orlando, and Tampa. The company also focuses on land purchasing and development to support future construction efforts as well as mortgage services for its homebuyers.

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.

Share on Social Networks: